Introduction {#s1}
============

Breast cancer, the second leading cause of cancer death in women, is responsible for the death of 1 in 52 women below 50 years of age (American Cancer Society, [@B3]). The American Cancer Society estimated that there will be 255,180 new breast cancer cases (2,470 men and 252,710 women) in the US by 2017 (American Cancer Society, [@B3]). Based on the immuno histochemical classification of hormone receptor status in the cancerous breast cells, there are 4 major groups of breast cancers: endocrine receptor (estrogen or progesterone receptor) positive (abbreviated in the study as BRER), human epidermal growth factor receptor 2 (HER2) positive (abbreviated in the study as BRHR), triple positive (estrogen, progesterone and HER2 receptor positive) (abbreviated in the study as BRTP) and triple negative (absence of estrogen, progesterone and HER2 receptors) (abbreviated in the study as BRTN) (Schnitt, [@B43]; American Cancer Society, [@B3]). These four types have specific prognoses and responses to therapy. Specifically, the hormone receptor positive breast cancers (BRER, BRTP) respond to endocrine therapy and show better prognosis, while the hormone receptor negative types (BRHR, BRTN) are more aggressive, non-responsive to endocrine therapy and have poor prognosis (Schnitt, [@B43]). BRTN cancer is seen in 15--20% of breast cancer patients, is the most aggressive of all the breast cancers, is unresponsive to treatment, highly angiogenic, proliferative and has the lowest survival rate (Siegel et al., [@B45]).

However in the recent times the global gene expression studies have identified breast tumors further into distinct molecular classes based on the expression level of endocrine receptors, proliferative genes, oncogenes and other genes; luminal A (ER+/PR+ and Ki67 high), luminal B (ER+/PR+, Ki67 low or, ER+/PR+/HE R2+), HER2+, basal (ER-/PR-/basal myoepithelial markers high/ EGFR+), and normal breast-like (ER-/PR-/basal myoepithelial markers-/EGFR-) (Yersal and Barutca, [@B52]).

Among the risk factors to develop cancer in general, infectious agents are known to be the third highest after tobacco usage and obesity, contributing 15--20% of cancer incidence (Morales-Sanchez and Fuentes-Panana, [@B36]). Age and genetic pre-disposition are also known cancer risk factors; however, the majority of cancers have unknown etiology (Madigan et al., [@B33]). Recent studies of microbiome dysbiosis in human health suggest specific changes in the microbiome in a number of disease states (Turnbaugh et al., [@B47]; Xuan et al., [@B51]; Chen and Wei, [@B16]), including cancer (Sheflin et al., [@B44]; Xuan et al., [@B51]). Further, studies have suggested the association of particular micro-organisms with specific cancers (Banerjee et al., [@B11], [@B9],[@B10]; Chen and Wei, [@B16]). Thus, a distinct microbiome may contribute to the cause or development of cancer. Conversely, the tumor micro-environment may provide a specialized niche in which these viruses and microorganisms may persist. In either case, cancer-type specific microbial signatures may provide clues for early diagnosis, prognosis and the design of treatment strategies.

We have recently identified a distinct microbial signature associated with triple negative breast cancer (Banerjee et al., [@B11]). In the present study we asked whether the microbial signatures associated with BRTN are shared by other breast cancer types, or do different breast cancer types have unique signatures. To study this we screened BRTN, BRTP, BRER, and BRHR samples using PathoChip, a pan-pathogen array containing oligonucleotide probes for the detection of all known, sequenced viruses, as well as known human bacterial, parasitic, and fungal pathogens. Additionally, PathoChip contains viral family specific conserved probes that allow for detection of uncharacterized members of the viral families (Baldwin et al., [@B7]). The PathoChip screen includes a whole genome and transcriptome amplification step that allowed detection of very low copy number of both DNA and RNA viruses and micro-organisms from the cancer tissues (Baldwin et al., [@B7]; Banerjee et al., [@B11]). Our analyses now show distinct microbial signatures for BRTN and BRTP samples, while the BRER and BRHR samples had similar microbial signatures.

Materials and methods {#s2}
=====================

Study samples
-------------

The study was approved by the institutional review board at the University of Pennsylvania (Protocol number 819358). All methods were performed in accordance with the relevant guidelines and regulations and reviewed by resident pathologists at the UPENN hospital. In the present study, 50 endocrine receptor (estrogen or progesterone receptor) positive (abbreviated as BRER in the study), 34 human epidermal growth factor receptor 2 (HER2) positive (abbreviated as BRHR in the study), 24 triple positive (estrogen, progesterone and HER2 receptor positive) (abbreviated as BRTP in the study) and 40 triple negative (absence of estrogen, progesterone and HER2 receptors, abbreviated as BRTN in the study) breast cancer tissues were included along with 20 breast control samples from healthy individuals. Due to HIPAA regulations, we could not obtain any information regarding the type of treatment these breast cancer patients received, or, if they were new patients. These tissues were obtained as de-identified archived samples. Tumors needing macro-dissection were received in the form of 10 μm sections on glass slides with marked guiding H&E slides, while tumors that did not require macro-dissection were received as 10 μm paraffin rolls. The 20 non-matched control tissues were derived from breast reduction surgeries and obtained as 10 μm paraffin rolls. Our resident pathologist reviewed case history, confirmed the tumor types and demarcated the cancer cells. All the samples were de-identified FFPE (formalin fixed paraffin embedded) samples of breast tumors or controls, and were received from the Abramson Cancer Center Tumor Tissue and Biosample Core. Extreme care was taken to avoid contamination during cutting of the FFPE sections (Banerjee et al., [@B11]). For each samples, microtome and other equipments were cleaned with 70% ethanol. Further, a new blade was used to prepare and cut each sample, and the area was also de-contaminated before cutting each sample (Banerjee et al., [@B11]).

Pathochip design, sample preparation, and microarray processing
---------------------------------------------------------------

The PathoChip Array design has been previously described in detail (Baldwin et al., [@B7]). The PathoChip probes were generated *in silico* using the genome sequences of all known viruses, as well as known human bacterial, parasitic and fungal pathogens. The PathoChip comprises 60,000 probe sets manufactured as SurePrint glass slide microarrays (Agilent Technologies Inc.), containing 8 replicate arrays per slide. Each probe is a 60-nt DNA oligomer that targets multiple genomic regions of the micro-organisms, for example, 18S rRNA gene, 5.8S rRNA gene, 28S rRNA gene, ITS1 and ITS2 for parasite detections, 16S rRNA gene for bacteria detections, 18S rRNA gene, ITS1, 5.8S rRNA gene, ITS2 and 26S rRNA gene to detect fungi, and conserved and specific viral genes to detect viral families and specific viruses. PathoChip screening was done using both DNA and RNA extracted from formalin-fixed paraffin-embedded (FFPE) tumor tissues as described previously (Baldwin et al., [@B7]; Banerjee et al., [@B11]). The quality of the extracted nucleic acids was determined by agarose gel electrophoresis and the A260/280 ratio. The extracted RNA and DNA were subjected to whole genome and transcriptome co-amplification (WTA) as previously described (Banerjee et al., [@B11]). A non-template control (RNAase/DNAase free water) was used during the WTA step, to determine if any contamination was present during the amplification step. The quality of the WTA products was determined by agarose gel electrophoresis. Human reference RNA and DNA were also extracted from the human B cell line, BJAB and were used for WTA as previously described (Banerjee et al., [@B11]). The WTA products were purified, (PCR purification kit, Qiagen, Germantown, MD, USA); the WTA products from the cancers were labeled with Cy3 and those from the human reference DNA were labeled with Cy5 (SureTag labeling kit, Agilent Technologies, Santa Clara, CA). The labeled DNAs were purified and hybridized to the PathoChip as described previously (Banerjee et al., [@B11]). Post-hybridization, the slides were washed, scanned and visualized using an Agilent SureScan G4900DA array scanner (Banerjee et al., [@B11]).

The question of potential contamination of FFPE blocks or during processing is always a concern. In these experiments all samples were handled and processed in the pathology laboratory using standard aseptic conditions. Likewise the preparation of the DNA and RNA from the samples was done in a dedicated laboratory under established condition designed to minimize laboratory contamination.

Microarray data extraction and statistical analysis
---------------------------------------------------

Agilent Feature Extraction software (Baldwin et al., [@B7]; Banerjee et al., [@B11]) was used to extract the raw data from the microarray images. We used the R program for normalization and data analyses (R Core Team, [@B38]). We calculated scale factor using the signals of green (Cy3) and red (Cy5) channels for human probes. Scale factors are the sum of green/sum of red signal ratios of human probes. Then we used scale factors to obtain normalized signals for all other probes. For all probes except human probes, normalized signal is log2 transformed of green signals/scale factors modified red signals (log2 g -- scale factor ^\*^ log2 r). On the normalized signals, one-sided *t*-test is applied to select probes significantly present in cancer samples by comparing cancer samples vs. controls. The significance cut-off was log2 fold change of signal ≥1 and adjusted *p*-value (all *p*-value were adjusted via Benjamini--Hochberg procedure for controlling FDR) ≤0.01, control prevalence ≤25%, case prevalence ≥40%. Prevalence is calculated as the detection of the microbial signatures in the cancer and in the control samples as percentages. For a particular microbial signature with multiple probes, we calculated the prevalence of that signature by calculating the maximum number of samples that contained even one of the probes of that signature.

The cancer samples were also subjected to hierarchical clustering, based on the detection of microbial signatures in the samples. We used hierarchical clustering technic (Euclidean distance, complete linkage, normalized hybridization signals not scaled) to cluster samples which were represented as heatmaps (Kolde, [@B28]). Then clusters were further validated by CH- index (Calinski and Harabasz index) which is implemented in the R package as NbClust (Charrad et al., [@B15]). CH- index is a cluster index that maximizes inter-cluster distances and minimizes intra-cluster distances. We calculated the possible cluster solution that would maximize the index values to achieve the best clustering of the data. Statistical significance between different groups was determined using the two-sided *t*-test.

Based on the clinical outcomes of the different breast cancer patients, the cases for each breast cancer types were divided into two groups: alive and deceased (with severe outcomes) (Supplementary Table [S4](#SM2){ref-type="supplementary-material"}). We calculated the proportion of the two groups in each of the hierarchical cluster/sub-cluster of the 4 breast cancer types. One sided *t*-test was also done to compare the differences of average hybridization signals of organisms in these two groups. Nominal *p*-values along with log fold change were calculated. Microbial signatures that were detected with significantly (nominal *p*-value \< 0.05) higher average hybridization signal in the deceased cases or in the patients that survived were selected to do box plots for representation of the data. Also differences in the detection of some signatures which were not statistically significant between the different outcomes, but showed some trend were plotted as well. Where, the *p*-value \> 0.05, we can only suggest that higher detection of those microbial signatures with either of the outcome, is only seen as a trend.

PCR validation of pathochip results
-----------------------------------

PCR primers from the conserved and/or specific regions of the micro-organisms detected by PathoChip screen were used. The PCR amplification reaction mixtures for each reaction contained 200-400 ng of WTA product and 20 pM each of forward and reverse primers (**Table 7**), 300 μM of dNTPs and 2.5U of LongAmp Taq DNA polymerase (NEB). DNA was denatured at 94°C for 3 min, followed by 30 cycles of 94°C for 30 s, different annealing temperature for different set of primers for 30--45 s, and 65°C for 30 s. The PCR conditions for each of the primer sets are mentioned in **Table 7**.

Results {#s3}
=======

Microbial signatures associated with different breast cancer types
------------------------------------------------------------------

Unique and common microbial signatures associated with different breast cancer types have been listed in Table [1](#T1){ref-type="table"} and are represented in Figures [1A](#F1){ref-type="fig"}, [2B](#F2){ref-type="fig"}, [3C,F](#F3){ref-type="fig"}. To establish the microbial signatures in the cancers we compared the average hybridization signal for each probe in the cancer samples vs. the controls. Those probes that detected significant higher hybridization signals in the cancer samples (*p*-value \< 0.05, log2 fold change in hybridization signal \> 1), present in atleast 40% of the cancer samples, and ≤25% of the controls were considered in the present study. A stringent cut-off criteria of microbial signature detections only in the cancers and not (0% prevalence) in the controls lead mostly to detect less number of probes for a particular signature for some signatures, not for all, but not that the majority signatures detected with our accepted cut-off was lost (Supplementary Figures [S2a](#SM2){ref-type="supplementary-material"}--[d](#SM2){ref-type="supplementary-material"}).

###### 

Unique and common microbial signatures in 4 breast cancer types; the endocrine receptor positives (BRER), human epidermal growth factor receptor 2 positives (BRHR), triple positives (BRTP) and the triple negatives (BRTN).

  **Cancer types**       **Viral signatures**                                                                                                                                                                                                                                   **Bacterial signatures**                                                                                         **Fungal signatures**                             **Parasitic signatures**
  ---------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ---------------------------------------------------------------------------------------------------------------- ------------------------------------------------- -----------------------------------------------------------------------------------------------
  BRER                                                                                                                                                                                                                                                                          Arcanobacterium, Bifidobacterium, Cardiobacterium, Citrobacter, Escherichia                                      Filobasidilla, Mucor, Trichophyton                Brugia, Paragonimus
  BRHR                   Nodaviridae                                                                                                                                                                                                                                            Streptococcus                                                                                                    Epidermophyton, Fonsecaea, Pseudallescheria       Balamuthia
  BRTP                   Birnaviridae, Hepeviridae                                                                                                                                                                                                                              Bordetella, Campylobacter, Chlamydia, Chlamydophila, Legionella, Pasteurella                                     Penicillium                                       Ancylostoma, Angiostrongylus, Echinococcus, Sarcocystis, Trichomonas, Trichostrongylus
  BRTN                                                                                                                                                                                                                                                                          Aerococcus, Arcobacter, Geobacillus, Orientia, Rothia                                                            Alternaria, Malassezia, Piedraia, Rhizomucor      Centrocestus, Contracaecum, Leishmania, Necator, Onchocerca, Toxocara, Trichinella, Trichuris
  BRTN+BRER                                                                                                                                                                                                                                                                     Mycoplasma                                                                                                                                                         
  BRTN+BRTP                                                                                                                                                                                                                                                                                                                                                                                                                                        Babesia, Mansonella, Schistosoma
  BRER+BRTN                                                                                                                                                                                                                                                                                                                                                                                      Fusarium                                          
  BRER+BRHR              Caliciviridae                                                                                                                                                                                                                                          Acinetobacter, Alcaligenes, Anaplasma, Eikenella, Fusobacterium, Kingella, Lactococcus, Salmonella                                                                 Ascaris
  BRHR+BRTP              Arteriviridae                                                                                                                                                                                                                                          Borrelia, Klebsiella                                                                                             Coccidioides                                      
  BRHR+BRTN                                                                                                                                                                                                                                                                                                                                                                                                                                        Strongyloides
  BRER+BRTP              Hepadnaviridae                                                                                                                                                                                                                                         Helicobacter, Neisseria, Pediococcus, Prevotella, Propionibacterium, Treponema                                   Cunninghamella, Geotrichum                        Hartmannella, Hymenolepis, Macracanthorhynchus
  BRTN+BRER+BRTP                                                                                                                                                                                                                                                                Stenotrophomonas                                                                                                 Pleistophora, Rhodotorula                         Naegleria
  BRTN+BRER+BRHR                                                                                                                                                                                                                                                                Brucella, Caulobacter, Peptoniphilus                                                                                                                               
  BRHR+BRTN+BRTP                                                                                                                                                                                                                                                                Haemophilus                                                                                                                                                        
  BRHR+BRTP+BRER         Astroviridae, Circoviridae, Orthomyxoviridae, Polyomaviridae, Togaviridae                                                                                                                                                                              Agrobacterium, Clostridium, Corynebacterium, Erysipelothrix, Lactobacillus, Listeria, Shigella, Staphylococcus   Ajellomyces, Aspergillus, Candida, Trichosporon   Entamoeba, Plasmodium, Thelazia
  BRER+BRHR+BRTP +BRTN   Adenoviridae, Anelloviridae, Arenaviridae, Bunyaviridae, Coronaviridae, Filoviridae, Flaviviridae, Herpesviridae, Iridoviridae, Papillomaviridae, Paramyxoviridae, Parvoviridae, Picornaviridae, Poxviridae, Reoviridae, Retroviridae, Rhabdoviridae   Actinomyces, Bartonella, Brevundimonas, Coxiella, Mobiluncus, Mycobacterium, Rickettsia, Sphingomonas                                                              

![Viral signatures associated with different breast cancer types. Among the breast cancer types, the endocrine receptor (estrogen/progesterone) positives are abbreviated as BRER, human epidermal growth factor receptor 2 positives are abbreviated as BRHR, triple positives (estrogen, progesterone and HER2 receptor positive) are abbreviated as BRTP and the triple negatives (absence of estrogen, progesterone and HER2 receptors) are abbreviated as BRTN. The normal breast control samples obtained from healthy individuals are abbreviated as NC. **(A)** Venn diagram showing the common and unique viral signatures in the 4 types of breast cancers. **(B)** The heat map of common viral signatures in the 4 breast cancer types. **(C)** Relative hybridization signals of viral probes detected in breast cancer types. For example, hybridization signals for Polyomaviridae probes were 4, 6, and 3% of the total hybridization signals detected in BRER, BRTP, and BRHR respectively. **(D)** Prevalence of viral signatures in 4 breast cancer types. Since the hybridization signals for Polyomaviridae, Hepadnaviridae and Parapoxviridae were lower than the cut-off (log2 fold change in hybridization signal \>1) in one or more breast cancer types they are depicted as negative in this figure. However, **(E)** shows the heat map of hybridization signals for those viral signatures to be still significantly higher in the cancers when compared to the control.](fmicb-09-00951-g0001){#F1}

![Bacterial signatures associated with different breast cancer types. Among the breast cancer types, the endocrine receptor (estrogen/progesterone) positives are abbreviated as BRER, human epidermal growth factor receptor 2 positives are abbreviated as BRHR, triple positives (estrogen, progesterone and HER2 receptor positive) are abbreviated as BRTP and the triple negatives (absence of estrogen, progesterone and HER2 receptors) are abbreviated as BRTN. The normal breast control samples obtained from healthy individuals are abbreviated as NC. **(A)** Bacterial phyla associated with breast cancer types. **(B)** Venn diagram showing the common and unique bacterial signatures in the 4 types of breast cancers **(C)**. The heat map of common viral signatures in the 4 breast cancer types. **(D)** Hybridization signals of bacterial probes detected in breast cancer types. **(E)** Prevalence of bacterial signatures in 4 breast cancer types.](fmicb-09-00951-g0002){#F2}

![Fungal and parasitic signatures associated with different breast cancer types. Among the breast cancer types, the endocrine receptor (estrogen/progesterone) positives are abbreviated as BRER, human epidermal growth factor receptor 2 positives are abbreviated as BRHR, triple positives (estrogen, progesterone, and HER2 receptor positive) are abbreviated as BRTP and the triple negatives (absence of estrogen, progesterone, and HER2 receptors) are abbreviated as BRTN. The normal breast control samples obtained from healthy individuals are abbreviated as NC. **(A)** Relative hybridization signals of fungal probes detected in breast cancer types. For example hybridization signals for *Ajellomyces* were 7, 8, and 14% of the total hybridization signals detected in BRER, BRTP, and BRHR respectively, and that of *Rhizomucor* is 19% of the hybridization signals detected in BRTN. **(B)** Prevalence of viral signatures in 4 breast cancer types. **(C)** Venn diagram showing the common and unique fungal signatures in the 4 types of breast cancers. **(D)** Relative hybridization signals of parasitic probes detected in breast cancer types. For example hybridization signals for *Plasmodium* were 10, 6, and 21% of the total hybridization signals detected in BRER, BRTP, and BRHR respectively, and that of *Mansonella* is 7 and 12% of the hybridization signals detected in BRTP and BRTN respectively. **(E)** Prevalence of parasitic signatures in 4 breast cancer types. **(F)** Venn diagram showing the common and unique parasitic signatures in the 4 types of breast cancers.](fmicb-09-00951-g0003){#F3}

We further averaged the hybridization signals of all the significant probes for each microbial genera and viral families, shown in the Figures [1](#F1){ref-type="fig"}--[3](#F3){ref-type="fig"}. Supplementary Table [S1](#SM1){ref-type="supplementary-material"} shows the average hybridization signals of the probes of microorganisms significantly detected in the cancers vs. the controls, with respective adjusted *p*-values with multiple corrections. Supplementary Table [S2](#SM2){ref-type="supplementary-material"} shows the proportion of probes that were detected significantly in each of the breast cancer types vs. the controls. Supplementary Figure [S1](#SM2){ref-type="supplementary-material"} shows the average fold change in hybridization signal intensity for the significantly detected probes of each of the signatures detected in the different breast cancer types over their respective signals in the control breast samples. Additionally, we calculated the percent prevalence of the significant microbial signatures in the cancer samples, which indicate how prevalent a significant virus or microorganism signature is in the cancer samples regardless of the hybridization intensity.

Viral signatures associated with different breast cancer types
--------------------------------------------------------------

Significant hybridization (described above), at levels above the controls, was detected for 28 viral families among the four breast cancer types (Figures [1A,D](#F1){ref-type="fig"}). Of these, 17 viral families were detected with significantly higher hybridization signals in greater than 50% of the samples representing all 4 breast cancer types, as compared to the controls (Figures [1B,D](#F1){ref-type="fig"}). They include signatures of Adenoviridae, Anelloviridae, Arenaviridae, Bunyaviridae, Coronaviridae, Filoviridae, Flaviviridae, Herpesviridae, Iridoviridae, Papillomaviridae, Paramyxoviridae, Parvoviridae, Picornaviridae, Poxviridae, Reoviridae, Retroviridae, and Rhabdoviridae (Figure [1B](#F1){ref-type="fig"}). Importantly, in examining the percent hybridization signal (Figure [1C](#F1){ref-type="fig"}) and percent prevalence (Figure [1D](#F1){ref-type="fig"}) we find that there were a number of viral families significantly detected only in a subset of breast cancer types. Specifically, the signatures for Birnaviridae and Hepeviridae were only detected in BRTP; and Nodaviridae only in BRHR (Figures [1C,D](#F1){ref-type="fig"}). Further examination of the percent prevalence (Figure [1D](#F1){ref-type="fig"}), shows that BRTN samples show low or no prevalence of Arteriviridae, Astroviridae, Birnaviridae, Caliciviridae, Circoviridae, Hepadnaviridae, Nodaviridae, Orthomyxoviridae, Polyomaviridae, and Togaviridae; BRHR samples show low or no prevalence of Birnaviridae, Hepadnaviridae, and Hepeviridae; BRTP samples show low or no prevalence of Caliciviridae and Nodaviridae; and BRER samples show low or no prevalence of Arteriviridae, Birnaviridae, Hepeviridae, and Nodaviridae.

Hybridization signal intensity offers an additional way to compare the data. Here we noted marked differences for specific viral families between the different breast cancer types. For example, probes for polyomaviridae were detected with the highest hybridization signal in the BRHRs, followed by BRERs and BRTPs (Figure [1E](#F1){ref-type="fig"}). Polyomaviridae were detected in the BRTNs compared to the controls; however, at a lower hybridization signal (log2 fold change in hybridization signal = 0.4--1; Figure [1E](#F1){ref-type="fig"}) which is below the cut-off to consider the signal positive, thus polyomaviridae are not shown to be present in the BRTNs in Figure [1C](#F1){ref-type="fig"} or Figure [1D](#F1){ref-type="fig"}. Similarly, probes of Hepadnaviridae were significantly detected with low hybridization signal in the BRTNs (Figure [1E](#F1){ref-type="fig"}), while detected with higher hybridization signal intensity (log2 fold change in hybridization signal \>1) in the BRERs and BRTPs (Figure [1E](#F1){ref-type="fig"}).

Signatures of Herpesviridae, Adenoviridae and Poxviridae were detected in \>90% of the BRER samples screened (Figure [1D](#F1){ref-type="fig"}), while the highest hybridization signal was detected for Anelloviridae and Flaviviridae (Figure [1B](#F1){ref-type="fig"}). Signatures of Astroviridae, Herpesviridae, Reoviridae were detected in all of the BRTP samples tested (Figure [1D](#F1){ref-type="fig"}), with the highest hybridization signal detected for Polyomaviridae signatures (Figure [1C](#F1){ref-type="fig"}). For BRHR samples, signatures of Reoviridae and Flaviviridae were detected in \>90% of the samples screened (Figure [1D](#F1){ref-type="fig"}), with signatures of Togaviridae showing the highest hybridization signal (Figure [1C](#F1){ref-type="fig"}). Among the BRTN samples, we detected signatures of Reoviridae in 90% of the samples screened (Figure [1D](#F1){ref-type="fig"}), with signatures of Picornaviridae and Anelloviridae with the highest hybridization signal (Figure [1B](#F1){ref-type="fig"}).

Probes of Poxviridae family were detected significantly in \>80% of all the breast cancer types analyzed. Interestingly, probes of Parapoxviridae were detected significantly with high hybridization signal intensity in BRER cancers vs. the controls (Figure [1E](#F1){ref-type="fig"}). Probes of Parapoxviridae were also detected significantly in the other 3 types of breast cancers compared to the controls, but showed much lower hybridization signal intensity for those probes (log2 fold change in hybridization signal \~0.5) (Figure [1E](#F1){ref-type="fig"}).

The data show that the cancer samples as a whole have a robust viral signature. However, there are significant and defining differences between the four types with BRTN having the least complex viral signature.

In the healthy control breast tissues, signatures of the viral families Arteriviridae, Hepadnaviridae, Hepeviridae, and Nodaviridae were not detected which were detected in one or more of the cancer types (Figure [1D](#F1){ref-type="fig"}).

Bacterial signatures associated with different breast cancer types
------------------------------------------------------------------

Figures [2A--E](#F2){ref-type="fig"} shows the analysis of bacterial signatures in the 4 breast cancer types. Significant hybridization, above the levels of the controls, was detected for 56 bacterial genera; the majority (50--60%) was proteobacteria, the major group of gram negative bacteria. These phyla partitioned into bacterial signatures unique to each cancer types, as well as signatures that were common to multiple breast cancer types (Table [1](#T1){ref-type="table"}, Figures [2B--D](#F2){ref-type="fig"}). Significant hybridization signals common to all 4 breast cancer types were detected for *Actinomyces, Bartonella, Brevundimonas, Coxiella, Mobiluncus, Mycobacterium, Rickettsia*, and *Sphingomonas* (Figures [2B,C](#F2){ref-type="fig"}).

The marked diversity in bacterial signatures between the breast cancer types are shown in Figure [2B](#F2){ref-type="fig"}. We identified distinct bacterial signatures uniquely associated with each type of breast cancer analyzed. In this regard BRTN had the least complex bacterial signature, while BRER is the most complex (Figures [2D,E](#F2){ref-type="fig"}). Signals for *Arcanobacterium, Bifidobacterium, Cardiobacterium, Citrobacter, Escherichia* were significantly detected in the BRER samples compared to the controls, while those of *Bordetella, Campylobacter, Chlamydia, Chlamydophila, Legionella*, and *Pasteurella* were significantly associated with the BRTPs. Signals for *Streptococcus* were detected significantly in the BRHRs, whereas, *Aerococcus, Arcobacter, Geobacillus, Orientia*, and *Rothia* were found associated with the BRTNs.

Hybridization signal intensity again provides an additional view of the complexity of the bacterial community and its diversity among the different breast cancers (Figures [2C,D](#F2){ref-type="fig"}). Signals for *Brevundimonas* were detected with higher average hybridization signals in the endocrine receptor positive BRER and BRTP compared to the endocrine receptor negative BRHR and BRTN (Figures [2C,D](#F2){ref-type="fig"}). Hybridization signals of *Mobiluncus* and *Mycobacterium* were predominantly detected in the endocrine receptor negative samples.

Bacterial signatures of *Actinomyces* were detected in all 4 cancer types; however their hybridization signal intensity was markedly lower in the BRTN samples (Figure [2C](#F2){ref-type="fig"}). Similarly, *Bartonella* was significantly detected in all cancer types, but its hybridization signal intensity was markedly lower in the BRER samples compared to the others (Figure [2C](#F2){ref-type="fig"}). The bacterial probes detected with the highest hybridization signals were those for *Acinetobacter* in BRER and BRHR samples, *Brevundimonas* in BRTP samples and *Caulobacter* in BRTN samples (Figure [2D](#F2){ref-type="fig"}). As in the case of the viruses our data show that the cancer samples have a robust bacterial signature with significant and defining differences between the four breast cancer types. The healthy control samples did not have some of the bacterial signatures that were detected in one or more of the cancer types, namely, *Actinomyces, Aerococcus, Arcanobacterium, Bifidobacterium, Bordetella, Cardiobacterium, Corynebacterium, Eikenella, Fusobacterium, Geobacillus, Helicobacter, Kingella, Orientia, Pasteurella, Peptinophilus, Prevotella, Rothia, Salmonella*, and *Treponema* (Figure [2E](#F2){ref-type="fig"}).

Fungal signatures associated with different breast cancer types
---------------------------------------------------------------

Significant hybridization, above the levels of the controls, was detected for 21 different genera of fungi among the 4 types of breast cancer (Figures [3A,B](#F3){ref-type="fig"}). Interestingly, none of these families were detected in all four cancer types (Figures [3B,C](#F3){ref-type="fig"}). In fact the fungi signatures for each type of breast cancer were relatively unique; only 7 fungal families (*Aspergillus, Candida, Coccidioides, Cunninghamella, Geotrichum, Pleistophora*, and *Rhodotorula*) were detected in more than one type of breast cancer. The receptor positive cancer samples (BRER and BRTPs) showed much more complex fungal diversity than the BRTN samples (Figures [3A,B](#F3){ref-type="fig"}). Table [1](#T1){ref-type="table"} and Figure [3C](#F3){ref-type="fig"} show the unique fungal signatures associated with different breast cancer types. Fungal signatures of *Filobasidiella, Mucor*, and *Trichophyton* were found to be significantly associated with BRER samples, *Penicillium* with BRTP samples, *Epidermophyton, Fonsecaea, Pseudallescheria* with BRHR samples and *Alternaria, Malassezia, Piedraia*, and *Rhizomucor* with BRTN samples. Fungal signatures of *Ajellomyces, Alternaria, Cunninghamella, Epidermophyton, Filobasidiella, Rhizomucor*, and *Trichophyton* detected in one or more breast cancer types were not detected in the healthy controls (Figure [3B](#F3){ref-type="fig"}).

Parasitic signatures associated with different breast cancer types
------------------------------------------------------------------

Significant hybridization, above the levels of the controls, was detected for 29 different genera of parasites among the 4 types of breast cancer (Figures [3D,E](#F3){ref-type="fig"}). As in the case of the fungi, no single genus of parasite was significantly detected in all four breast cancer types (Figures [3E,F](#F3){ref-type="fig"}). Each cancer showed a relatively distinct parasitic signature pattern, with BRHR showing the least diverse signatures. Table [1](#T1){ref-type="table"} and Figure [3F](#F3){ref-type="fig"} shows the unique and common parasitic signatures among the different breast cancer types.

Analysis of hybridization signal intensity in Figure [3D](#F3){ref-type="fig"} shows that *Plasmodium* was detected with the highest hybridization signal in the BRHR samples and also detected in the BRER samples and BRTP samples but not in BRTN samples. In BRTN the highest hybridization signal intensity was detected for the probes of *Mansonella* followed by *Centrocestus*, whereas *Strongyloides* was detected in almost all of the BRTN samples. *Naegleria* was detected with the highest hybridization signal intensity in BRTP (Figure [3D](#F3){ref-type="fig"}) while *Sarcocystis* and *Babesia* were detected in 92% of BRTP samples (Figure [3E](#F3){ref-type="fig"}). Among the BRER samples, *Brugia* showed the highest hybridization signal intensity (Figure [3D](#F3){ref-type="fig"}), while *Thelazia* showed the highest prevalence (Figure [3E](#F3){ref-type="fig"}). Signatures of *Brugia* and *Paragonimus* were only detected in BRER samples (Table [1](#T1){ref-type="table"}, Figures [3D,E](#F3){ref-type="fig"}). *Ancylostoma, Angiostrongylus, Echinococcus, Sarcocystis, Trichomonas, Trichostrongylus* were found uniquely associated with BRTP samples (Table [1](#T1){ref-type="table"}, Figures [3D--F](#F3){ref-type="fig"}). *Balamuthia* signatures were associated significantly with BRHR samples, and that of *Centrocestus, Contracaecum, Leishmania, Necator, Onchocerca, Toxocara, Trichinella*, and *Trichuris* were detected significantly only with BRTN samples (Table [1](#T1){ref-type="table"}, Figures [3D--F](#F3){ref-type="fig"}). Signatures of *Ancylostoma, Ascaris, Centrocestus, Contracaecum, Hartmanella, Leishmania, Paragonimus, Thelazia, Toxocara, Trichinella, Trichuris* detected in one or more cancer types were not detected in the healthy controls (Figure [3E](#F3){ref-type="fig"}).

Hierarchical clustering of the breast cancer samples based on the detection of microbial signatures
---------------------------------------------------------------------------------------------------

Using the hierarchical clustering analysis based on the detection of microbial signatures associated with the 4 breast cancer types we determine if the breast cancer types fell into any unique and identifiable clusters. While this analysis identified distinct clusters in each of the breast cancer types based on the detection of their microbial signature patterns (Figures [4A--D](#F4){ref-type="fig"}), it also defined the distinct microbial signature pattern found in BRTNs and BRTPs whereas, BRER and BRHR shared similar microbial signatures (Figure [4E](#F4){ref-type="fig"}).

![Hierarchical clustering of BRER **(A)**, BRTP **(B)**, BRHR **(C)**, BRTN **(D)**, and all 4 breast cancer types **(E)** based on their microbial signature detection pattern. The endocrine receptor (estrogen/progesterone) positive breast cancers are abbreviated as BRER, human epidermal growth factor receptor 2 positive breast cancers are abbreviated as BRHR, triple positive (estrogen, progesterone, and HER2 receptor positive) breast cancers are abbreviated as BRTP and the triple negative (absence of estrogen, progesterone, and HER2 receptors) breast cancers are abbreviated as BRTN.](fmicb-09-00951-g0004){#F4}

Individually, the different BC types fell into distinct microbial signature clusters. BRER samples fell into 2 distinct clusters 1ER and 2ER, along with 2 ungrouped samples (ungrouped 1ER) (Figure [4A](#F4){ref-type="fig"}). Samples grouped in Cluster 1ER and 2ER differed significantly based on the higher detection of mostly bacterial and viral and certain fungal and parasitic signatures in the samples of Cluster 2ER (Table [2](#T2){ref-type="table"}). The ungrouped BRER samples (ungrouped 1ER) were significantly different from clusters 1ER and 2ER (Table [2](#T2){ref-type="table"}).

###### 

Significant differences in microbial signatures between the hierarchical clusters of the endocrine receptor positive breast cancers (BRER).

  **Organism**                                          **T statistic**   ***P*-value**   **LogFC**
  ----------------------------------------------------- ----------------- --------------- -----------
  **BRER CLUSTER 1ER VS. CLUSTER 2ER IN FIGURE 4A**                                       
  Propionibacterium                                     −7.211            7.39E−07        −1.557
  Arcanobacterium                                       −7.194            2.25E−06        −1.616
  Brucella                                              −6.512            2.76E−05        −1.613
  Adenoviridae                                          −5.232            9.03E−05        −0.901
  Brevundimonas                                         −5.243            0.000166        −3.275
  Caulobacter                                           −5.296            0.0002          −1.858
  Pleistophora                                          −4.763            0.000346        −1.617
  Eikenella                                             −4.538            0.000435        −2.023
  Poxviridae                                            −4.644            0.000443        −0.823
  Filoviridae                                           −3.886            0.00056         −0.906
  Alcaligenes                                           −4.288            0.000854        −1.525
  Kingella                                              −4.275            0.000879        −1.954
  Reoviridae                                            −4.019            0.001078        −0.733
  Flaviviridae                                          −4.083            0.001118        −1.037
  Retroviridae                                          −3.926            0.001159        −1.087
  Erysipelothrix                                        −3.928            0.00116         −1.730
  Herpesviridae                                         −4.253            0.001288        −1.083
  Orthomyxoviridae                                      −4.033            0.001308        −1.030
  Papillomaviridae                                      −4.112            0.001326        −1.076
  Shigella                                              −3.685            0.001537        −1.190
  Astroviridae                                          −3.349            0.001945        −0.795
  Citrobacter                                           −3.552            0.002306        −1.063
  Macracanthorhynchus                                   −3.680            0.002931        −1.784
  Rickettsia                                            −3.409            0.004689        −1.169
  Coxiella                                              −3.490            0.004739        −2.031
  Trichophyton                                          −3.566            0.00481         −2.754
  Acinetobacter                                         −3.281            0.004871        −1.544
  Escherichia                                           −3.366            0.005736        −1.493
  Mycoplasma                                            −3.250            0.006671        −1.627
  Staphylococcus                                        −3.098            0.007102        −0.751
  Paramyxoviridae                                       −3.059            0.007333        −0.621
  Aeromonas                                             −3.024            0.007923        −0.984
  Pediococcus                                           −3.129            0.008223        −1.645
  Mucor                                                 −3.220            0.008331        −2.103
  Brugia                                                −3.065            0.009069        −1.711
  Paragonimus                                           −2.766            0.014456        −1.021
  Polyomaviridae                                        −2.750            0.015486        −1.258
  Rhabdoviridae                                         −2.825            0.016266        −0.913
  Stenotrophomonas                                      −2.808            0.016458        −1.617
  Parvoviridae                                          −2.594            0.017333        −0.465
  Rhodotorula                                           −2.723            0.018918        −0.915
  Cardiobacterium                                       −2.726            0.020259        −1.386
  Prevotella                                            −2.521            0.020957        −0.911
  Treponema                                             −2.660            0.022602        −1.820
  Circoviridae                                          −2.587            0.02349         −1.135
  Bunyaviridae                                          −2.544            0.025934        −0.772
  Hymenolepis                                           −2.547            0.026229        −1.566
  Hartmannella                                          −2.452            0.027852        −0.837
  Plasmodium                                            −2.334            0.029775        −0.646
  Sphingomonas                                          −2.440            0.033178        −1.495
  Corynebacterium                                       −2.314            0.036828        −1.463
  Lactobacillus                                         −2.284            0.040908        −0.887
  Anelloviridae                                         −2.246            0.041582        −0.867
  Aspergillus                                           −2.232            0.046187        −1.222
  **BRER CLUSTER 1ER VS. UNGROUPED 1ER IN FIGURE 4A**                                     
  Pleistophora                                          −28.365           4.78E−13        −4.105
  Brugia                                                −7.866            1.87E−08        −1.653
  Escherichia                                           −30.534           6.54E−08        −4.933
  Neisseria                                             −6.310            4.77E−07        −1.466
  Retroviridae                                          −13.206           0.000123        −2.407
  Coxiella                                              −11.147           0.000156        −2.297
  Togaviridae                                           −4.362            0.000578        −0.742
  Papillomaviridae                                      −9.237            0.011952        −1.470
  Citrobacter                                           −12.427           0.011967        −3.997
  Brucella                                              −12.872           0.013747        −2.140
  Corynebacterium                                       −7.594            0.015709        −3.346
  Fusobacterium                                         −8.502            0.040745        −5.272
  Rickettsia                                            −2.767            0.045012        −0.457
  **BRER CLUSTER 2ER VS. UNGROUPED 1ER IN FIGURE 4A**                                     
  Retroviridae                                          −4.822            0.00084         −1.320
  Citrobacter                                           −7.684            0.003969        −2.934
  Corynebacterium                                       −2.730            0.027196        −1.883
  Escherichia                                           −7.864            8.52E−06        −3.439
  Fusobacterium                                         −6.841            0.017391        −4.806
  Neisseria                                             −2.315            0.042091        −1.067
  Pleistophora                                          −7.693            1.07E−05        −2.489

Majority of the BRTP samples had similar microbial detections and grouped together into 1 major cluster (cluster 1TP), while few samples remained ungrouped (Figure [4B](#F4){ref-type="fig"}).

The BRHR samples formed 2 major clusters (cluster 1HR and cluster 2HR) (Figure [4C](#F4){ref-type="fig"}), and they differed from each other in having higher detection of certain bacterial and viral signatures in cluster 2HR compared to samples in cluster 1HR (Table [3](#T3){ref-type="table"}). Bacterial signatures of *Kingella, Brevundimonas, Eikenella, Bartonella, Acinetobacter, Nodaviridae, Actinomyces, Aeromonas, Mobiluncus, Fusobacterium, Alcaligenes, Brucella*, and *Staphylococcus*; viral signatures of Orthomyxoviridae, Parvoviridae, Papillomaviridae, Nodaviridae, and Astroviridae and fungal signatures of *Aspergillus* showed significant higher detection in cluster 2HR. The 3 BRHRs that could not be grouped (ungrouped 1HR and 2HR) showed higher detection of certain microbial signatures listed in Table [3](#T3){ref-type="table"} compared to the clustered BRHR samples; in particular, included the parasitic signature of *Entamoeba* and bacterial signatures of *Listeria* and *Corynebacterium*.

###### 

Significant differences in microbial signatures between the hierarchical clusters of the human epidermal growth factor receptor 2 positive breast cancers (BRHR).

  **Organism**                                                    **T statistic**   ***P*-value**   **LogFC**
  --------------------------------------------------------------- ----------------- --------------- -----------
  **BRHR CLUSTER 1HR VS. CLUSTER 2HR IN FIGURE 4C**                                                 
  Kingella                                                        −8.239            8.7E−09         −2.185
  Brevundimonas                                                   −9.967            2.3E−08         −2.411
  Eikenella                                                       −6.587            4.2E−07         −2.008
  Bartonella                                                      −7.715            5.8E−07         −1.759
  Acinetobacter                                                   −5.766            9.3E−06         −2.858
  Nodaviridae                                                     −5.598            1.4E−05         −2.066
  Actinomyces                                                     −5.389            1.8E−05         −2.445
  Aeromonas                                                       −6.501            1.9E−05         −2.143
  Mobiluncus                                                      −4.808            9.1E−05         −2.027
  Fusobacterium                                                   −4.200            0.00059         −1.741
  Alcaligenes                                                     −4.352            0.00065         −1.164
  Brucella                                                        −3.442            0.00319         −0.891
  Orthomyxoviridae                                                3.186             0.00422         1.180
  Parvoviridae                                                    −2.993            0.00666         −0.516
  Aspergillus                                                     −2.517            0.02244         −1.169
  Papillomaviridae                                                −2.427            0.02385         −0.449
  Staphylococcus                                                  −2.073            0.04818         −1.147
  Astroviridae                                                    −2.128            0.04831         −0.642
  **BRHR CLUSTER 1HR VS. UNGROUPED(1HR**+**2HR), IN FIGURE 4C**                                     
  Lactobacillus                                                   −8.722            5E-07           −3.149
  Paramyxoviridae                                                 −8.701            7E-07           −1.295
  Entamoeba                                                       −14.273           4E-05           −6.228
  Anaplasma                                                       −9.105            2E-04           −1.783
  Astroviridae                                                    −7.437            0.003           −1.825
  Staphylococcus                                                  −3.735            0.004           −1.758
  Brucella                                                        −6.840            0.011           −2.152
  Mobiluncus                                                      −5.976            0.011           −3.399
  Rhabdoviridae                                                   −6.586            0.013           −2.423
  Klebsiella                                                      −3.389            0.017           −2.348
  Actinomyces                                                     −3.952            0.02            −2.016
  Candida                                                         −4.990            0.025           −2.924
  Flaviviridae                                                    −5.242            0.026           −2.677
  Caliciviridae                                                   −3.043            0.027           −1.220
  Ascaris                                                         −3.655            0.03            −2.466
  Arenaviridae                                                    −4.007            0.035           −2.163
  Corynebacterium                                                 −4.706            0.038           −4.514
  Lactococcus                                                     −2.652            0.04            −0.769
  Bartonella                                                      −4.347            0.042           −1.957
  Listeria                                                        −4.206            0.043           −3.924
  Thelazia                                                        −3.931            0.045           −3.126
  Papillomaviridae                                                −3.901            0.048           −1.585
  Anelloviridae                                                   −2.520            0.048           −1.859
  Poxviridae                                                      −4.155            0.049           −2.570
  **BRHR CLUSTER 2HR VS. UNGROUPED(1HR+2HR) IN FIGURE 4C**                                          
  Entamoeba                                                       −15.712           0.0001          −6.501
  Paramyxoviridae                                                 −4.736            0.0003          −1.116
  Lactobacillus                                                   −4.561            0.0005          −2.908
  Anaplasma                                                       −4.400            0.0007          −1.343
  Nodaviridae                                                     4.850             0.0032          2.267
  Astroviridae                                                    −3.418            0.0068          −1.183
  Rhabdoviridae                                                   −4.586            0.008           −1.980
  Candida                                                         −5.384            0.0193          −3.190
  Klebsiella                                                      −4.734            0.0197          −2.750
  Brucella                                                        −3.320            0.0209          −1.261
  Flaviviridae                                                    −4.883            0.021           −2.601
  Listeria                                                        −4.088            0.026           −4.122
  Arenaviridae                                                    −3.471            0.0344          −1.991
  Ascaris                                                         −3.922            0.0368          −2.499
  Anelloviridae                                                   −3.885            0.0375          −2.349
  Corynebacterium                                                 −4.125            0.0408          −4.068

The BRTN samples formed two distinct clusters (cluster 1TN and 2TN) with 2 samples that did not cluster into distinct group (ungrouped 1TN) (Figure [4D](#F4){ref-type="fig"}). Cluster 1TN differed from Cluster 2TN in having higher detection of bacterial probes of *Caulobacter, Brevundimonas, Peptoniphilus, Rothia, Geobacillus, Aerococcus, Mobiluncus, Actinomyces, Bartonella*, fungal probes of *Malassezia, Piedraia, Rhodotorula, Rhizomucor* and parasitic signatures of *Leishmania, Toxocara, Contracaecum, Centrocestus, Trichuris, Strongyloides* (Table [4](#T4){ref-type="table"}). Whereas, samples in Cluster 2TN had significant higher hybridization signal intensity for viral signatures of Poxviridae, Paramyxoviridae, Reoviridae, Parvoviridae, Arenaviridae, bacterial signatures of *Sphingomonas, Brucella, Orientia, Stenotrophomonas*, fungal signatures of *Pleistophora* and parasitic signatures of *Trichinella*. The ungrouped samples differed from the grouped samples in having significantly higher detection of certain viral probes of Anelloviridae, Retroviridae, Poxviridae, and Arenaviridae compared to Cluster 1TN and Cluster 2TN samples (Table [4](#T4){ref-type="table"}).

###### 

Significant differences in microbial signatures between the hierarchical clusters of the triple negative breast cancers (BRTN).

  **Organism**                                          **T statistic**   ***P*-value**   **LogFC**
  ----------------------------------------------------- ----------------- --------------- -----------
  **BRTN CLUSTER 1TN VS CLUSTER 2TN IN FIGURE 4D**                                        
  Caulobacter                                           14.725            5E-16           4.006
  Brevundimonas                                         16.431            5E-15           3.496
  Peptoniphilus                                         12.519            9E-11           3.326
  Rothia                                                10.847            4E-10           2.647
  Geobacillus                                           11.926            3E-09           2.917
  Aerococcus                                            12.298            3E-09           2.544
  Mobiluncus                                            8.106             1E-08           2.793
  Leishmania                                            6.619             2E-07           1.256
  Actinomyces                                           6.417             2E-07           1.837
  Malassezia                                            6.015             1E-06           1.598
  Toxocara                                              5.734             4E-06           1.387
  Contracaecum                                          5.814             4E-06           1.176
  Piedraia                                              5.368             6E-06           0.815
  Rhodotorula                                           5.298             6E-06           1.402
  Centrocestus                                          5.325             2E-05           1.720
  Rhizomucor                                            5.023             3E-05           1.413
  Trichuris                                             4.913             3E-05           1.267
  Strongyloides                                         4.814             4E-05           1.110
  Bartonella                                            4.524             2E-04           1.901
  Poxviridae                                            −3.959            3E-04           −0.504
  Paramyxoviridae                                       −3.773            6E-04           −1.022
  Sphingomonas                                          −3.686            9E-04           −1.264
  Pleistophora                                          3.640             0.001           1.097
  Reoviridae                                            −2.987            0.005           −0.539
  Trichinella                                           2.916             0.006           1.062
  Arenaviridae                                          −2.845            0.008           −0.713
  Brucella                                              −2.748            0.01            −1.098
  Orientia                                              −2.521            0.018           −0.942
  Parvoviridae                                          −2.294            0.028           −0.701
  Stenotrophomonas                                      −2.231            0.032           −0.533
  **BRTN CLUSTER 1TN VS CLUSTER 1TN IN FIGURE 4D**                                        
  Anelloviridae                                         −18.960           4E-05           −8.958
  Retroviridae                                          −20.048           6E-11           −6.108
  Poxviridae                                            −25.133           1E-13           −1.989
  Arenaviridae                                          −10.652           4E-08           −1.201
  Iridoviridae                                          3.061             0.008           0.972
  Mycoplasma                                            2.912             0.011           1.102
  Trichinella                                           4.806             3E-04           1.146
  Rickettsia                                            2.916             0.011           1.156
  Adenoviridae                                          2.848             0.013           1.178
  Filoviridae                                           3.956             0.001           1.226
  Actinomyces                                           6.995             4E-05           1.605
  Babesia                                               7.967             1E-06           1.648
  Aerococcus                                            6.799             0.014           2.342
  Toxocara                                              28.244            1E-13           2.495
  Rothia                                                13.228            3E-09           2.874
  Centrocestus                                          13.652            0.036           2.912
  Peptoniphilus                                         14.486            8E-10           3.518
  **BRTN CLUSTER 2TN VS. UNGROUPED 1TN IN FIGURE 4D**                                     
  Anelloviridae                                         −23.294           0.0007          −9.497
  Retroviridae                                          −18.299           2E-12           −5.681
  Poxviridae                                            −14.532           5E-13           −1.485
  Arenaviridae                                          −2.111            0.0459          −0.488
  Rickettsia                                            3.576             0.0017          1.064
  Filoviridae                                           3.714             0.0012          1.100
  Toxocara                                              4.920             6E-05           1.108
  Centrocestus                                          3.124             0.0122          1.192
  Adenoviridae                                          2.834             0.0097          1.249
  Iridoviridae                                          4.805             8E-05           1.341
  Babesia                                               5.584             1E-05           1.556
  Mycoplasma                                            4.207             0.0004          1.701

Figure [4E](#F4){ref-type="fig"} shows the comparison of the microbial signatures from all four breast cancer types together in the clustering analysis. The data show that the different breast cancers grouped into 4 major clusters plus a few ungrouped BRER (2 samples), BRHR (3 samples), and BRTN (2 samples) samples (ungrouped 1, 2, and 3 respectively). Most of the BRTNs were very distinct in their microbial signature pattern association, and they clustered together (cluster 3). Similarly all the BRTPs screened clustered together to form a distinct cluster 4. Conversely, most of the BRER samples shared a similar microbial signature pattern with all of the BRHR samples forming the distinct cluster 1, while the remaining 11 BRER samples formed cluster 2. The BRERs in cluster 2 differed from those in Cluster 1 in having significant higher hybridization signals for certain bacterial signatures like *Brevundimonas, Sphingomonas, Erysipelothrix, Mycoplasma, Brucella, Prevotella, Arcanobacterium, Staphylococcus, Rickettsia, Propionibacterium, Lactobacillus, Shigella*, viral signatures of Polyomaviridae, Circoviridae, Herpesviridae, Papillomaviridae, Retroviridae, Orthomyxoviridae, Flaviviridae, Iridoviridae, Poxviridae, Reoviridae, fungal signatures of *Trichophyton, Mucor, Rhodotorula, Geotrichum, Pleistophora* and parasitic signatures of *Paragonimus, Macracanthorhynchus, Hartmannella* (Table [5](#T5){ref-type="table"}).

###### 

Significant differences in microbial signatures between the hierarchical clusters of the endocrine receptor positive breast cancers of cluster 1 vs. 2 in Figure [4E](#F4){ref-type="fig"}.

  **Organism**          **T statistic**   ***P*-value**   **LogFC**   **Types**
  --------------------- ----------------- --------------- ----------- -----------
  Trichophyton          −4.156            0.002           −3.067      Fungal
  Mucor                 −4.269            0.001           −2.400      Fungal
  Brevundimonas         −2.357            0.033           −1.966      Bacterial
  Sphingomonas          −3.025            0.012           −1.781      Bacterial
  Erysipelothrix        −2.685            0.018           −1.725      Bacterial
  Mycoplasma            −3.094            0.009           −1.598      Bacterial
  Polyomaviridae        −4.103            7E-04           −1.511      Viral
  Paragonimus           −3.974            0.001           −1.448      Parasitic
  Macracanthorhynchus   −3.362            0.004           −1.437      Parasitic
  Brucella              −4.795            3E-04           −1.419      Bacterial
  Circoviridae          −2.985            0.011           −1.292      Viral
  Prevotella            −2.306            0.04            −1.291      Bacterial
  Hartmannella          −3.531            0.003           −1.183      Parasitic
  Rhodotorula           −2.323            0.04            −1.116      Fungal
  Herpesviridae         −2.669            0.022           −1.088      Viral
  Geotrichum            −2.352            0.034           −1.015      Fungal
  Arcanobacterium       −2.949            0.011           −1.013      Bacterial
  Pleistophora          −2.163            0.047           −0.989      Fungal
  Papillomaviridae      −2.913            0.013           −0.917      Viral
  Staphylococcus        −3.037            0.009           −0.909      Bacterial
  Retroviridae          −2.452            0.027           −0.876      Viral
  Orthomyxoviridae      −3.343            0.005           −0.863      Viral
  Rickettsia            −2.321            0.037           −0.852      Bacterial
  Flaviviridae          −2.814            0.014           −0.851      Viral
  Propionibacterium     −2.354            0.033           −0.834      Bacterial
  Iridoviridae          −2.539            0.022           −0.830      Viral
  Poxviridae            −2.732            0.019           −0.787      Viral
  Lactobacillus         −2.271            0.04            −0.781      Bacterial
  Shigella              −2.171            0.042           −0.735      Bacterial
  Reoviridae            −2.579            0.023           −0.655      Viral

Thus, we identified specific microbial signature patterns associated with different breast cancer types. It will be interesting to see if such distinct microbial signature pattern associated with different breast cancer types, correlate to differences in pathogenesis and clinical outcome.

Association of microbial signatures with clinical outcomes in the four breast cancer types
------------------------------------------------------------------------------------------

The samples we used in this study were de-identified samples. Thus due to HIPPA regulations we were able to procure only limited sub-set of data from the Tumor Registry. This included outcome, specifically whether the patient was alive or dead since diagnosis and treatment; the cause of death and length of survival were not available. These data provide only indications of trends which will have to be statistically verified in future studies using samples with associated clinical data.

For these analyses the hierarchical clustering for each of the four different breast cancer types were further grouped into sub-clusters based on microbial detections (Figure [5A](#F5){ref-type="fig"}). In the BRTNs the cases of sub-cluster 2b had the highest (63%) proportion of the patients who had died, followed by that of Cluster 1 (33%); while sub-clusters 2a and 2c had a higher number of surviving patients (Figure [5B](#F5){ref-type="fig"}). The shared feature of sub-clusters 1 and 2b is a higher detection of fungal and parasitic signatures (Figure [5A](#F5){ref-type="fig"}). BRTP samples did not fall into discrete sub-clusters (Figure [5A](#F5){ref-type="fig"}), but overall BRTP showed 82% surviving patients. For BRER samples, sub-clusters 1a, b and c had similar numbers of patients who had died (25, 22, and 33%, respectively), while these numbers were much lower for sub-clusters 2a and 2b. Sub-clusters 2a and 2b are notable in that they have an overall more robust and diverse microbial signature. Examining the sub-clusters for BRHR shows a high number of surviving patients in all sub-clusters (1a, 1b, and 2; 75, 86, and 85%, respectively). Within the limits of the data these analyses suggest that the specific microbial signatures may correlate with outcome especially in the case of BRTN.

![Heat map of hierarchical clustering of the 4 types of breast cancers **(A)**, and the proportion of patients with and without severe outcome (death) in each cluster/sub-cluster **(B)**. Among the breast cancer samples, the endocrine receptor (estrogen/progesterone) positives are abbreviated as BRER, human epidermal growth factor receptor 2 positives are abbreviated as BRHR, triple positives (estrogen, progesterone, and HER2 receptor positive) are abbreviated as BRTP and the triple negatives (absence of estrogen, progesterone, and HER2 receptors) are abbreviated as BRTN.](fmicb-09-00951-g0005){#F5}

Using the survival data, we also examined variation in average hybridization signal for microbial signatures between the breast cancer types (Figure [6](#F6){ref-type="fig"} and Table [6](#T6){ref-type="table"}). Interestingly, these analyses showed that high hybridization signals of specific viruses and microbes in a particular breast cancer type may trend with patients who had died, others trended with surviving patients. For example, in BRTP Herpesviridae signatures were detected significantly higher in BRTP patients who had died. Similarly, BRTN patients who had died had significant higher hybridization signals for certain fungal (*Malassezia, Rhizomucor, Rhodotorula*) and parasitic (*Centrocestus, Strongyloides, Trichuris, Contracaecum, Leishmania*) signatures. In the BRERs we found a trend of higher detection of the bacterium *Peptinophilus* signatures in the deceased cases. Similarly, we found a trend of higher detection of certain bacteria (*Listeria, Lactobacillus, Borrelia*) in the BRHR cases with severe outcome.

![Box plots representing either significant or trend of higher detection of microbial signatures in BRTN **(A)**, BRTP **(B)**, BRER **(C)**, and BRHR **(D)** cases with low (alive) or severe (dead) clinical outcomes, compared by one sided *t*-test. The *p*-value of the tests is shown in the figure if significant. NS represents non-significant test, however still a trend cannot be ignored. Among the breast cancer types, the endocrine receptor (estrogen/progesterone) positives are abbreviated as BRER, human epidermal growth factor receptor 2 positives are abbreviated as BRHR, triple positives (estrogen, progesterone, and HER2 receptor positive) are abbreviated as BRTP and the triple negatives (absence of estrogen, progesterone, and HER2 receptors) are abbreviated as BRTN.](fmicb-09-00951-g0006){#F6}

###### 

One sided *t*-test of microbial signature detection in different breast cancer types \[endocrine receptor positives (BRER), human epidermal growth factor receptor 2 positives (BRHR), triple positives (BRTP) and the triple negatives (BRTN)\], with their clinical outcome.

  **Organism**                         ***p-*value**   **Adjust *p*-value**   **logFC**
  ------------------------------------ --------------- ---------------------- -----------
  **BRTN_DECEASED_VS_ALIVE_T\_TEST**                                          
  *Centrocestus*                       0.0053          0.129                  0.752
  *Strongyloides*                      0.00667         0.129                  0.546
  *Trichuris*                          0.00708         0.129                  0.745
  *Malassezia*                         0.0119          0.129                  0.701
  *Contracaecum*                       0.01253         0.129                  0.664
  *Leishmania*                         0.0138          0.129                  0.752
  *Rhizomucor*                         0.01642         0.131                  0.631
  *Rhodotorula*                        0.01881         0.132                  0.79
  **BRTN_ALIVE_VS_DECEASED_T\_TEST**                                          
  Paramyxoviridae                      0.00131         0.0733                 1.251
  Filoviridae                          0.00586         0.1642                 1.578
  *Onchocerca*                         0.01925         0.282                  1.466
  *Orientia*                           0.02014         0.282                  1.809
  *Schistosoma*                        0.03627         0.4062                 1.393
  *Arcobacter*                         0.04846         0.4191                 1.147
  **BRTN_DECEASED_VS_ALIVE_T\_TEST**                                          
  Herpesviridae                        0.02802         0.9685                 0.282
  **BRTN_ALIVE_VS_DECEASED_T\_TEST**                                          
  Astroviridae                         0.00072         0.0512                 1.339
  Anelloviridae                        0.00179         0.0512                 3.241
  *Campylobacter*                      0.00181         0.0512                 2.478
  *Coccidioides*                       0.01974         0.4195                 2.257
  Hepeviridae                          0.0313          0.5018                 1.44
  *Angiostrongylus*                    0.0368          0.5018                 2.033
  Adenoviridae                         0.04206         0.5018                 0.327
  **BRTN_DECEASED_VS_ALIVE_T\_TEST**                                          
  *Peptoniphilus*                      0.10238         0.9997                 0.879
  **BRTN_ALIVE_VS_DECEASED_T\_TEST**                                          
  *Eikenella*                          0.00027         0.0154                 2.179
  *Kingella*                           0.00047         0.0154                 2.111
  *Caulobacter*                        0.00071         0.0154                 2.23
  Polyomaviridae                       0.00073         0.0154                 2.26
  *Geotrichum*                         0.00089         0.0154                 1.362
  *Alcaligenes*                        0.00146         0.0211                 1.735
  *Ajellomyces*                        0.00206         0.0256                 2.114
  *Escherichia*                        0.00239         0.026                  1.465
  Circoviridae                         0.00405         0.0391                 1.203
  *Cardiobacterium*                    0.00603         0.0485                 1.659
  *Helicobacter*                       0.00715         0.0485                 1.869
  *Anaplasma*                          0.00758         0.0485                 1.697
  *Arcanobacterium*                    0.00762         0.0485                 1.135
  Herpesviridae                        0.00781         0.0485                 0.696
  **BRTN_DECEASED_VS_ALIVE_T\_TEST**                                          
  *Listeria*                           0.08097         1                      2.008
  *Lactobacillus*                      0.17059         1                      0.811
  *Borrelia*                           0.20093         1                      0.762
  **BRTN_ALIVE_VS_DECEASED_T\_TEST**                                          
  *Sphingomonas*                       3.03*E*−05      0.0021                 2.825
  *Aspergillus*                        8.41*E*−05      0.0029                 2.239
  *Coxiella*                           0.00086         0.02                   1.865
  *Candida*                            0.00188         0.0328                 1.154
  *Epidermophyton*                     0.00306         0.0428                 2.234

*Nominal p-value (p-value) and p-value with multiple correction (adjust p-value) for each microbial signature detection along with the log2 fold change (logFC) for the t-tests are mentioned*.

Conversely, high hybridization signals for Paramyxoviridae, Astroviridae, and Polyomaviridae were found with greater frequency, respectively, in the BRTN, BRTP, and BRER cancer patients who survived. Additionally, high hybridization signals for the bacteria *Sphingomonas* and the fungus *Aspergillus* were detected in the BRHR patients who survived. Again within the limits of the clinical data these finding suggest that the qualitative and quantitative nature of the microbial signatures associated with a patient\'s cancer may provide diagnostic and prognostic information.

Validation of pathochip screen results by PCR
---------------------------------------------

We selected several viruses and microorganisms detected in the BC samples for verification by non-quantitative PCR and sequencing, these included several viral families and individual viruses (Herpesvirus, Polyoma, Papilloma, Parapox, and MMTV), as well as a prevalent bacterium (*Brevundimonas*), and fungus (*Pleistophora*). The primers used were either previously published (Table [7](#T7){ref-type="table"}) or were designed based on sequences from the conserved and specific regions of the micro-organisms. For detection of parasites we used pan-parasite diagnostic PCR primers enabling exhaustive detection of non-human eukaryotic species-specific small subunit rDNA in human clinical samples. For the validation experiments we used the WTA prepared and used for the initial screening. The PCR amplification showed the expected amplicons for the PathoChip-detected viruses, as well as the selected bacterium, fungus and parasite (Figure [7](#F7){ref-type="fig"}). Sequencing of the PCR products verified the detection of the appropriate virus or other microorganism (Supplementary Table [S3](#SM2){ref-type="supplementary-material"}, Supplementary Figure [S3](#SM2){ref-type="supplementary-material"}).

###### 

Primers used for PCR validation of PathoChip screen.

  **Micro-organism**                 **Primers**                **Sequence (5′-3′)**                                             **Annealing temp and time**   **Extension temp and time**   **Amplicon size (bp)**   **Detail**
  ---------------------------------- -------------------------- ---------------------------------------------------------------- ----------------------------- ----------------------------- ------------------------ -----------------------------------------------
  Herpes                             FP 1                       GAA GAC GCT GAT GAA CCA CG                                       51°C for 45 s                 65°C for 20 s                 96                       Self-designed
                                     RP 2                       AAG CAC CTG GTG TAC TTT CAC                                                                                                                           
  Mouse mammary tumor virus (MMTV)   SN FP 5 (gag) RP 6 (gag)   ACT CAG AAG GAA ACC CCT GCC TC ATC TCC TTT TTC CCT GGC CTC TGC   57°C for 30 s                 65°C for 30 s                 70                       Self-designed
  HPV                                HPV GP5                    TTTGTTACTGTGGTAGATACTA                                           43°C for30 s                  65°C for 30 s                 104--141                 Self-designed
                                     HPV gp6                    GAAAAATAAACTGTAAATCATATTC                                                                                                                             
  Polyoma                            PYV.for PYV.rev            GGAAAGTCTTTAGGGTCTTCTACC TAGGTGCCAACCTATGGAACAGA                 53°C for 30 s                 65°C for 30 s                 178--183                 N Engl J Med 1992; 326:988--993 April 9, 1992
  Parapox                            FP                         ATC TTC ACG GGC GCA GTC G                                        56°C for 30 s                 65°C for 30 s                 286                      Self-designed
                                     RP                         CTC TTC GAC GAC GAC GGG AAC                                                                                                                           
  Bacteria *Brevundimonas*           FP 17 RP 18                TTG CAG AGG ACA ATC CGA ACT GAG AAC TGC CTT TGA TAC TGG CGA TC   52°C for 30 s                 65°C for 60 s                 667                      Self-designed
  Fungus *Pleistophora*              FP 19                      AGG TCT CCT AGG TGA ATA GCC                                      48°C for 30 s                 65°C for 30 s                 219                      Self-designed
                                     RP 20                      CCG TGC TTA CAG TTA TTT CCT C                                                                                                                         
  Parasite                           G3Fl G3Rl                  GCCAGCAGCCGCGGTAATTC ACATTCTTGGCAAATGCTTTCGCAG                   48°C for 30 s                 65°C for 30 s                 404                      Patents WO 2014071946 A1

![PCR validation of microbial signatures in the 4 types of breast cancers and healthy control, using the primers from Table [7](#T7){ref-type="table"}. Among the breast cancer types, the endocrine receptor (estrogen/progesterone) positives are abbreviated as BRER, human epidermal growth factor receptor 2 positives are abbreviated as BRHR, triple positives (estrogen, progesterone, and HER2 receptor positive) are abbreviated as BRTP and the triple negatives (absence of estrogen, progesterone, and HER2 receptors) are abbreviated as BRTN. The breast control samples obtained from healthy individuals are abbreviated as NC. The **left** shows the cropped gel pictures of EtBr stained amplicons run on agarose gel, where M is DNA ladder of RsaI digested ϕX/174, NTC is non-template control. The sequenced amplicons were subjected to nucleotide blast program in NCBI, and the results are shown in the **right**. In the Polyomavirus PCR gel picture, the orange and the green arrow heads signify Simian virus 40 and Merkel cell polyomavirus amplicons respectively, the electropherogram of the sequences of which are marked with the same arrow heads in Supplementary Figure [S3](#SM2){ref-type="supplementary-material"}.](fmicb-09-00951-g0007){#F7}

Discussions {#s4}
===========

The human microbiome is comprised of mutualistic, pathogenic, transient and residential viruses and microorganisms. Many recent studies have suggested that the body\'s microbiome dramatically affects health, where perturbation of the microbiome leads to altered physiology and pathology, including cancer. However, the reverse may also be true, that different human diseases create disease microenvironments amenable to the persistence of a differential microbiome, with or without a direct effect on the establishment or progression of the disease. Such differential microbiomes could be specific to each such disease. Using our in-house metagenomic array technology (PathoChip), we previously established distinct microbial signatures in triple negative breast cancers (BRTNs) (Banerjee et al., [@B11]). In the present study we determined the microbial signatures that were significantly higher in the 4 major breast cancer types (BRTN, BRTP, BRER, BRHR) compared to the healthy breast control tissues, and also determined whether the microbial signatures associated with the BRTNs was a specific feature of BRTNs, or a generic feature shared with other types of breast cancers.

Our data showed that the various breast cancers have robust and varied micro-organisms with aspects that are unique to each type as well as shared components. The data suggest that breast cancer microbial signatures may provide type-specific communities of organisms unique to each breast cancer type. We also point out that our control FFPE samples, processed in the same way as tumor samples, had different signatures, generally with much lower hybridization signals, arguing against gross contamination.

Examining viral signatures we found that the majority of the viral families detected were associated with all 4 breast cancer types. However, several important viruses were differentially detected; for example, among known oncogenic viruses the signatures of Polyomaviridae were detected with high significance and high signal intensity in the BRER and BRHR samples and with low signal intensity in the other breast cancer types. Signatures of Hepadnaviridae were similarly detected in BRER and BRTPs with high signal intensity, but with very low signal intensity in the other two cancer types. It is intriguing that signatures for Parapoxviridae family were found in all the breast cancers with BRERs showing the highest level of detection. Parapox viruses are known to have homologs to human genes responsible for angiogenesis (Ueda et al., [@B48]; Delhon et al., [@B17]).

There were a number of bacterial families shared by all four breast cancer types. For example, all four breast cancer types had dominant signatures for Proteobacteria followed by Firmicutes. The presence of these two bacterial phyla in the breast cancer tissues has been reported (Urbaniak et al., [@B49], [@B50]; Hieken et al., [@B26]), and suggested to be a result of adaptation to the fatty acid environment and metabolism in the tissue (Urbaniak et al., [@B49]). Another study found a positive correlation between Proteobacteria and the metabolic by-products of fatty acid metabolism, along with host-derived genes involved in fatty acid biosynthesis (El Aidy et al., [@B18]). In particular, the signature of the proteobacteria *Brevundimonas* genus was detected with high hybridization signal and prevalence in all four breast cancer types. *Brevundimonas* causes bacteremia and has been found associated with immunocompromised and/or cancer patients in other studies (Han and Andrade, [@B24]; Lee et al., [@B31]; Banerjee et al., [@B11]). Additionally, the *Mobiluncus* family was detected in all four types, it is mostly known to be associated with bacterial vaginosis (Gatti, [@B20]); however, the association of breast cancers may correlate with recent studies showing an association with breast abscesses and extragenital infections (Glupczynski et al., [@B21]; Sturm, [@B46]). We also detected Actinomyces signatures in all four breast cancers, especially in BRHRs where it was detected with very high signal intensity. Previous studies have reported Actinomycosis in the breast tissues of breast cancer patients (Aamir and Bokhari, [@B1]; Abdulrahman and Gateley, [@B2]; Banerjee et al., [@B11]), as primary (Salmasi et al., [@B41]), or secondary infections (Brunner et al., [@B14]) in breast, and in breast abscess (Attar et al., [@B5]). Additionally, each type of breast cancer held signatures for unique bacterial genera, and may provide an ability to detect specific breast cancer types.

Fungal infections in cancer patients are common. Among the fungal signatures we detected were yeasts like *Candida, Geotrichum, Rhodotorula, Trichosporon* as well as fungi causing Mucormycosis, Aspergillosis (cutaneous infections) and dermatophytes like *Epidermophyton* and *Trichophyton* are commonly known to be associated with cancers (Mays et al., [@B34]; Ansari et al., [@B4]; Banerjee et al., [@B11]; Jung et al., [@B27]; Rodríguez-Gutiérrez et al., [@B40]; Berkovits et al., [@B13]). Also, we detected *Fonsecaea* infection, which is seen to predispose squamous cell carcinoma development (Azevedo et al., [@B6]).

Possibly the most intriguing and unexpected result of the PathoChip screening is the detection of parasite signatures in different breast cancer types. These signatures were quite unique to the different breast cancer types with no signal parasite being prevalently found in all four. Many parasite signatures were distinctly detected in only one type of breast cancer. It should be kept in mind that our sensitive detection approach allows us to detect low abundance organisms, as well as unknown members of parasite families. However, the association of specific parasites with cancer is known. Among the parasites detected, *Trichinella* (detected in BRTN) has been found in a patient with recurrent ductal invasive breast carcinoma (Kristek et al., [@B30]). *Schistosoma* (detected in BRTN, BRTP) has been linked to bladder cancer (Samaras et al., [@B42]; Benamrouz et al., [@B12]); additionally we detected signatures of *Ascaris* (BRHR, BRER) and *Trichuris* (BRTN) which have been associated with pediatric cancers (Menon et al., [@B35]). Similarly, *Strongyloides* (BRTN, BRHR) has been associated with adult cancer patients (Guarner et al., [@B23]). Other signatures detected, *Leishmania* (BNTN) and *Plasmodium* (BRHR, BRTP, BRER), induce the inhibition of apoptosis (Heussler et al., [@B25]), which may promote oncogenesis (Lowe and Lin, [@B32]).

It was interesting to further investigate if detection of certain microbial signatures in breast cancers differed among patients who survived or died. We noticed higher detection of certain parasitic and fungal signatures in BRTN patients who died. Of particular interest in these analyses was the finding of high hybridization signals of specific viruses and microbes in a particular breast cancer type that may trend with patients who died, while others trended with surviving patients. Within the limits of the clinical data that could be provided, our findings suggest that the qualitative and quantitative nature of the microbial signatures associated with a patient\'s cancer may provide diagnostic and prognostic information.

Our findings suggest that the micro-organisms in breast cancers are diverse, extensive and have unique aspects that differentiate the four different breast cancers tested. We represented the microbial signatures that were significantly higher in the breast tumor microenvironment, when compared to healthy breast tissues. Some of these tumor microbial signatures overlapped with the reported skin microbiome (Findley and Grice, [@B19]; Hieken et al., [@B26]). For example: Bacteria like, *Lactobacillus, Prevotella, Staphylococcus, Lactococcus, Streptococcus* have been reported earlier as healthy breast skin flora (Hieken et al., [@B26]; Urbaniak et al., [@B50]), *Propionibacterium, Corynebacterium* bacteria, and *Malassezia* fungi has been reported to be common skin commensals (Grice and Segre, [@B22]). Although the detection of those common skin/healthy breast floras in the breast tumor microenvironment in the current study is not surprising, there still exists a breast tumor specific microbiome, which was also reported by other studies (Urbaniak et al., [@B49]; Xuan et al., [@B51]).

Many of the microbial signatures that were detected in one or more of the breast cancer types were not detected in the healthy controls, as mentioned in the results section. Most of those micro-organisms were found in earlier studies to be associated with cancer and/or immunocompromised patients (Kontoyianis et al., [@B29]; Menon et al., [@B35]; Narikiyo et al., [@B37]; Aamir and Bokhari, [@B1]; Kristek et al., [@B30]; Ramanan et al., [@B39]; Abdulrahman and Gateley, [@B2]; Banerjee et al., [@B11], [@B8]).

It is possible that micro-organisms in the breast cancer could contribute to the origin, potentiation or modulation of oncogenesis. However, it is equally possible that the tumor microenvironment provides favorable conditions for specific micro-organisms to persist more readily than in the normal tissue microenvironment. Moreover, due to HIPAA regulations we could not get any information on the type of treatment these breast cancer patients received. Thus, while we can only assume that the samples from some of the patients could be obtained before treatment, others could be receiving treatment already at the time of sample procurement. Especially patients already receiving treatment could be immunocompromised, which further exposes them to a higher infection rate, and thus detecting higher number of micro-organisms from those samples is not surprising.

Our data demonstrate for the first time that the microbial signatures of BRTN and BRTPs are distinct and significantly different from the microbial signatures largely shared by BRER and BRHR. Furthermore, the unique characteristics of the breast cancer associated microbial signatures potentially provide certain tools for specific diagnosis and treatment of these cancers. These findings are hypothesis-generating and needs further investigation to identify a microbial risk signature for the different breast cancer types and potential microbial-based prevention therapies. A complete review of the microbiome in these breast cancers and healthy controls would open up more insight into answering those questions.
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